Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Alcon Inc. (ALC:NYSE), powered by AI.
Alcon Inc. is currently trading at $74.56. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Alcon Inc. on Alpha Lenz.
Alcon Inc.'s P/E ratio is 36.2.
“Alcon Inc. trades at a P/E of 36.2 (premium valuation) with modest ROE of 4.8%.”
Ask for details →Alcon Inc. is a leading global company in the field of ophthalmology, specializing in the development and manufacturing of eye care devices and pharmaceutical products. Its primary purpose is to enhance and protect visual health through a comprehensive portfolio that includes contact lenses, surgical products such as implantables, consumables, and advanced surgical equipment. Alcon serves diverse segments of the eye care market, providing solutions for conditions like cataracts, glaucoma, retinal diseases, and refractive errors. The company is known for ongoing innovation, conducting numerous clinical trials and maintaining an active pipeline of new products through collaborations with medical institutions and research leaders. With a history dating back to 1945 and operations in over 140 countries, Alcon plays a significant role in both the medical device and pharmaceutical sectors, improving quality of life for millions by partnering with eye care professionals and advancing global access to eye health solutions.
“Alcon Inc. trades at a P/E of 36.2 (premium valuation) with modest ROE of 4.8%.”
Ask for details →